Cargando…

Age-dependent response to multimodal therapy for stage II-III rectal cancer

Detalles Bibliográficos
Autores principales:	Delitto, Daniel, Loftus, Tyler J., Iqbal, Atif
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659795/ https://www.ncbi.nlm.nih.gov/pubmed/31384389 http://dx.doi.org/10.18632/oncotarget.27084

Ejemplares similares

Pathologic stage dictates survival after neoadjuvant radiation for rectal cancer
por: Delitto, Daniel, et al.
Publicado: (2018)

Utility of Restaging MRI Following Neoadjuvant Chemoradiotherapy for Stage II-III Rectal Adenocarcinoma
por: Aryan, Mahmoud, et al.
Publicado: (2021)

Sigmoido-rectal intussusception
por: Filiberto, Amanda C, et al.
Publicado: (2019)

Rectal Cancer: Multimodal Treatment Approach
por: Pramateftakis, Manousos-Georgios, et al.
Publicado: (2012)

Contemporary, national patterns of surgery after preoperative therapy for stage II/III rectal adenocarcinoma
por: Soriano, Celine, et al.
Publicado: (2022)

Patterns of Pelvic Radiotherapy in Patients with Stage II/III Rectal Cancer
por: Fitzgerald, Timothy L., et al.
Publicado: (2013)

Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer
por: Sarasqueta, C., et al.
Publicado: (2019)

Mysteries, Epistemological Modesty, and Artificial Intelligence in Surgery
por: Loftus, Tyler J., et al.
Publicado: (2020)

The Survival Effect of Radiotherapy on Stage II/III Rectal Cancer in Different Age Groups: Formulating Radiotherapy Decision-Making Based on Age
por: Li, Yuqiang, et al.
Publicado: (2021)

A Predictive Genetic Signature for Response to Fluoropyrimidine-Based Neoadjuvant Chemoradiation in Clinical Stage II and III Rectal Cancer
por: Chan, Jason, et al.
Publicado: (2013)

Short-course or long-course radiation therapy as a part of a neoadjuvant regimen for stage II & III rectal adenocarcinoma?
por: Zhao, Nan, et al.
Publicado: (2019)

Is a Microsatellite Instability Still Useful for Tailored Treatment in Stage II and III Colon Cancer?
por: Kim, Nam Kyu
Publicado: (2014)

Which Definition of Upper Rectal Cancer Is Optimal in Selecting Stage II or III Rectal Cancer Patients to Avoid Postoperative Adjuvant Radiation?
por: Gao, Xian Hua, et al.
Publicado: (2021)

Stage II/III rectal cancer with intermediate response to preoperative radiochemotherapy: Do we have indications for individual risk stratification?
por: Sprenger, Thilo, et al.
Publicado: (2010)

Multimodal Therapy: Holistic Approach
por: Srinivasan, TM
Publicado: (2018)

Multimodality Imaging Training Curriculum — Parts II and III
Publicado: (2012)

Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III
por: Taal, B G, et al.
Publicado: (2001)

Pre-treatment platelet counts as a prognostic and predictive factor in stage II and III rectal adenocarcinoma
por: Steele, Morgan, et al.
Publicado: (2017)

Oncologic Outcomes of Postoperative Chemoradiotherapy Versus Chemotherapy Alone in Stage II and III Upper Rectal Cancer
por: Yoon, Ji Eun, et al.
Publicado: (2019)

Altered fractionation short-course radiotherapy for stage II-III rectal cancer: a retrospective study
por: Geinitz, Hans, et al.
Publicado: (2020)

Incremental Value of Radiomics in 5-Year Overall Survival Prediction for Stage II–III Rectal Cancer
por: Nie, Ke, et al.
Publicado: (2022)

The Conditioning of Adjuvant Chemotherapy for Stage II and III Rectal Cancer Determined by Postoperative Pathological Characteristics in Romania
por: Liscu, Horia-Dan, et al.
Publicado: (2023)

Monitoring neoadjuvant therapy responses in rectal cancer using multimodal nonlinear optical microscopy
por: Li, Lian-Huang, et al.
Publicado: (2017)

The Shortcomings of Radiologic Staging for Rectal Cancer and the Impact on the Treatment Plan
por: Alsanea, Nasser
Publicado: (2013)

Multimodal Therapy of Upper Gastrointestinal Malignancies
por: Ronellenfitsch, Ulrich, et al.
Publicado: (2021)

A robust circular RNA-based prognostic signature for postoperative recurrence in stage II/III colon cancer
por: Ruan, Ji
Publicado: (2019)

Differences in plasma TIMP-1 levels between healthy people and patients with rectal cancer stage II or III
por: Oblak, Irena, et al.
Publicado: (2011)

ALDH1 is an independent prognostic factor for patients with stages II–III rectal cancer after receiving radiochemotherapy
por: Deng, Y, et al.
Publicado: (2014)

Stage II/III Rectal Cancer Post-Treatment Surveillance Patterns of Care: A SEER- Medicare Study
por: Chioreso, Catherine, et al.
Publicado: (2021)

Impact of Adjuvant Therapy Type on Survival in Stage II/III Rectal Cancer Without Preoperative Chemoradiation: A Korean Multicenter Retrospective Study
por: Kang, Byung Mo, et al.
Publicado: (2018)

Preoperative and postoperative prognostic factors of patients with stage II/III lower rectal cancer without neoadjuvant therapy in the clinical trial (JCOG0212)
por: Ohue, Masayuki, et al.
Publicado: (2021)

The number of cycles of adjuvant chemotherapy in stage III and high-risk stage II rectal cancer: a nomogram and recursive partitioning analysis
por: Chen, Wei-Wei, et al.
Publicado: (2022)

Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II study
por: Zhu, Ji, et al.
Publicado: (2014)

A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinoma
por: Zhu, Ji, et al.
Publicado: (2013)

Stratified Prognostic Value of Pathological Response to Preoperative Treatment in yp II/III Rectal Cancer
por: Yang, Yanpeng, et al.
Publicado: (2021)

Stage III uterine serous carcinoma: modern trends in multimodality treatment
por: Li, Jessie Y., et al.
Publicado: (2020)

Interdisciplinary multimodality management of stage III nonsmall cell lung cancer
por: Huber, Rudolf M., et al.
Publicado: (2019)

Postoperative Chemoradiotherapy With Capecitabine and Oxaliplatin vs Capecitabine for Stage II to III Rectal Cancer: A Randomized Clinical Trial
por: Li, Ning, et al.
Publicado: (2021)

A prognostic nomogram for stage II/III rectal cancer patients treated with neoadjuvant chemoradiotherapy followed by surgical resection
por: Lin, Yanfei
Publicado: (2022)

Prognostic Significance of Lymph Node Ratio in Stage III Rectal Cancer
por: Shin, Jin Yong, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_7ut9ll5h45dsnvb9jadk2jllm0